Therapies for non-alcoholic fatty liver disease: A 2022 update

被引:0
|
作者
Katie Shen [1 ]
Achintya D Singh [1 ]
Jamak Modaresi Esfeh [2 ]
Jamile Wakim-Fleming [2 ]
机构
[1] Department of Internal Medicine, Cleveland Clinic Foundation
[2] Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation
关键词
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
The incidence of non-alcoholic fatty liver disease(NAFLD) is rapidly increasing and lifestyle interventions to treat this disease by addressing the underlying metabolic syndrome are often limited. Many pharmacological interventions are being studied to slow or even reverse NAFLD progression. This review for hepatologists aims to provide an updated understanding of the pathogenesis of NAFLD, current recommended therapies, and the most promising treatment options that are currently under development.
引用
收藏
页码:1718 / 1729
页数:12
相关论文
共 50 条
  • [31] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    [J]. ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [32] Non-alcoholic fatty liver disease
    Adams, LA
    Angulo, P
    [J]. LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
  • [33] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [34] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    [J]. CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [35] Non-alcoholic fatty liver disease
    Brent A. Neuschwander-Tetri
    [J]. BMC Medicine, 15
  • [36] Non-Alcoholic Fatty Liver Disease
    Engin, Atilla
    [J]. OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
  • [37] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
  • [38] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    [J]. LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
  • [39] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [40] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693